Table
1: Demographic
and clinical variables: Survivors§ and non-survivors.
Variables |
ECPR NON-SURVIVORS |
ECPR SURVIVORS |
P VALUE |
Total = 21N = 11(%) N = 10(%) |
|||
Demographics |
|||
Age at ECPR(days)(a) |
7.6 ± 2.8 |
7.4 ± 2.5 |
0.3 |
Diagnosis |
|
|
0.9 |
HLHS 8(73) 6(60) |
|
|
|
FSV (non-HLHS) |
3 (27) 4 (40) |
|
|
GS/CA |
2 (18) |
0 |
0.2 |
During ECPR |
|||
CPR duration(a) |
40.6 ± 6.9 |
37.2 ± 5.8 |
0.09 |
Peak PH (first 24 hrs) |
|
|
0.3 |
≤ 7.19 |
0 |
1 (10) |
|
7.2-7.34 |
6 (55) |
6 (60) |
|
≥ 7.35 |
5 (45) |
3 (30) |
|
Serum peak Lactate (first 24 hrs) (mmol/L) |
|
|
0.02 |
0-4.9 |
0 |
2 (20) |
|
5.0-9.9 |
2 (18) |
7 (70) |
|
≥ 10.0 |
9 (82) |
1 (10) |
|
Maximum VIS (first 24 hrs) |
|
|
0.7 |
≤ 19 |
6 (55) |
7 (70) |
|
20-24 |
4 (36) |
2 (20) |
|
≥ 25 |
1 (9) |
1 (10) |
|
Serum Creatinine (first 72 hrs) (mg/dl) |
|
|
0.7 |
≤ 1.0 |
8 (73) |
7 (70) |
|
1.1-1.6 |
1 (9) |
3 (30) |
|
≥ 1.7 |
2 (18) |
0 |
|
SV function (first 48 hrs) |
|
|
0.1 |
SVNL |
4 (36) |
6 (60) |
|
SVNL-1 |
2 (18) |
2 (20) |
|
SVNL-2 |
5 (45) |
2 (20) |
|
Negative fluid balance (days
following ECMO) |
|
|
0.7 |
≤ 3 |
5 (45) |
7 (70) |
|
≥ 4 |
6 (55) |
3 (30) |
|
(b)ECMO duration (days) |
|||
Peak PH (first 24 hrs) |
|
|
0.2 |
≤ 7.19 |
4 (36) |
1 (10) |
|
7.2-7.34 |
5 (45) |
5 (50) |
|
≥ 7.35 |
2 (18) |
4 (40) |
|
Serum peak Lactate (first 24 hrs) (mmol/L) |
|
|
0.6 |
0-4.9 |
2 (18) |
2 (20) |
|
5.0-9.9 |
7 (64) |
7 (70) |
|
≥ 10.0 |
6 (55) |
7 (70) |
|
20-24 |
4 (36) |
2 (20) |
|
≥ 25 |
1 (9) |
1 (10) |
|
Serum Creatinine (first 72 hrs) (mg/dl) |
|
|
0.7 |
≤ 1.0 |
8 (73) |
7 (70) |
|
1.1-1.6 |
1 (9) |
3 (30) |
|
≥ 1.7 |
2 (18) |
0 |
|
SV function (first 48 hrs) |
|
|
0.1 |
SVNL |
4 (36) |
6 (60) |
|
SVNL-1 |
2 (18) |
2 (20) |
|
SVNL-2 |
5 (45) |
2 (20) |
|
Negative fluid balance (days
following ECMO) |
|
|
0.7 |
≤ 3 |
5 (45) |
7 (70) |
|
≥ 4 |
6 (55) |
3 (30) |
|
ECMO duration (days)(b) |
9 (6-13) |
4 (3-7) |
0.01 |
Post- ECPR |
|
|
|
Peak PH (first 24 hrs) |
|
|
0.2 |
≤ 7.19 |
4 (36) |
1 (10) |
|
7.2-7.34 |
5 (45) |
5 (50) |
|
≥ 7.35 |
2 (18) |
4 (40) |
|
Serum peak Lactate (first 24 hrs) (mmol/L) |
|
|
0.6 |
0-4.9 |
2 (18) |
2 (20) |
|
5.0-9.9 |
7 (64) |
7 (70) |
|
≥ 10.0 |
2 (18) |
1 (10) |
|
Maximum VIS (first 24 hrs) |
|
|
0.6 |
≤14 |
2 (18) |
2 (20) |
|
15-19 |
4 (36) |
4 (40) |
|
20-24 |
4 (36) |
2 (20) |
|
≥ 25 |
1 (9) |
2 (20) |
|
Serum Creatinine (first 72 hrs) (mg/dl) |
|
|
0.7 |
≤ 1.0 |
4 (36) |
3 (30) |
|
1.1-1.6 |
5 (45) |
4 (40) |
|
≥ 1.7 |
2 (18) |
3 (30) |
|
Negative fluid balance (after ECMO decannulation) |
|
|
0.7 |
≤ 3 |
5 (45) |
6 (60) |
|
≥ 4 |
6 (55) |
4 (40) |
|
aMean ± SD; bMedian (25th
- 75th quartile); all categorical variables are expressed
frequencies or percentages; §follow-up (mean interval 17.4 ± 5.1
months)